Drisdol and Skin blushing/flushing - a phase IV clinical study of FDA data

Summary:

Skin blushing/flushing is reported as a side effect among people who take Drisdol (ergocalciferol), especially for people who are female, 50-59 old, also take Tecfidera, and have Multiple sclerosis.

The phase IV clinical study analyzes which people have Skin blushing/flushing when taking Drisdol. It is created by eHealthMe based on reports of 1,686 people who have side effects when taking Drisdol from the FDA, and is updated regularly.

What is Drisdol?

Drisdol has active ingredients of ergocalciferol. It is often used in vitamin d. eHealthMe is studying from 1,741 Drisdol users. Check the latest studies of Drisdol.

What is Skin blushing/flushing?

Skin blushing/flushing (a sudden reddening of the face, neck) is found to be associated with 2,008 drugs and 2,936 conditions by eHealthMe. Check the latest studies of Skin blushing/flushing.

eHealthMe: drug outcomes in the real world

eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.

On Sep, 02, 2026

1,686 people reported to have side effects when taking Drisdol.
Among them, 13 people (0.77%) have Skin blushing/flushing.

Could Drisdol cause Skin blushing/flushing?

Among these 13 people:

What is the gender of people who have Skin blushing/flushing when taking Drisdol? *

female: 100 %
male: 0.0 %

What is the age of people who have Skin blushing/flushing when taking Drisdol? *

What are other drugs people take besides Drisdol? *

What are other side effects people have besides Skin blushing/flushing? *

Fatigue (feeling of tiredness): 5 people, 38.46%
Nausea (feeling of having an urge to vomit): 5 people, 38.46%
Anaemia (lack of blood): 5 people, 38.46%
Nausea And Vomiting: 4 people, 30.77%
Dizziness: 4 people, 30.77%
Headache (pain in head): 4 people, 30.77%
Central Nervous System Lesion (an abnormality in tissue of brain or spinal cord): 3 people, 23.08%
Chest Pain: 3 people, 23.08%
Muscle Aches (muscle pain): 3 people, 23.08%
Osteopenia (a condition where bone mineral density is lower than normal): 3 people, 23.08%

What are the existing conditions these people have? *

Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 8 people, 61.54%
Stress And Anxiety: 4 people, 30.77%
Muscle Spasms (muscle contraction): 4 people, 30.77%
Nausea (feeling of having an urge to vomit): 3 people, 23.08%
Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 2 people, 15.38%
Pulmonary Hypertension (increase in blood pressure in the lung artery): 1 person, 7.69%
Iron Deficiency Anaemia: 1 person, 7.69%
Gait Disturbance: 1 person, 7.69%
Chronic Renal Failure (kidney failure): 1 person, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Drisdol and have Skin blushing/flushing?

- Check whether Skin blushing/flushing is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Drisdol:

Drisdol (1,741 reports)

Browse all side effects of Drisdol:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Skin blushing/flushing:

Skin blushing/flushing (2,008 drugs)

Browse all the conditions that are associated with Skin blushing/flushing:

Skin blushing/flushing (2,936 conditions)

Related publications that referenced our studies

Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .
Kapoor S, "Influence of Vitamin D Consumption and Levels on the Development of Psychiatric Disorders", Lee, Y. J., & Park, K. (2018). Secondary Raynaud’s Phenomenon and Skin Necrosis of Toes in the Paraplegic Patient with Hypertension.?Drug safety-case reports,?5(1), 7., 2014 Aug .

How the study uses the data?

The study uses data from the FDA. It is based on ergocalciferol (the active ingredients of Drisdol) and Drisdol (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.